Please login to the form below

Not currently logged in
Email:
Password:

Shield

This page shows the latest Shield news and features for those working in and with pharma, biotech and healthcare.

Smart solutions

Smart solutions

In the respiratory space, pharmaceutical companies face losing their patent shields on their blockbusters, at which time they fall vulnerable to generic competition.

Latest news

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Shaping healthcare Shaping healthcare

    that  shield the office from the nearby  M4 motorway have yet to regain their leaves.

  • Significant figures Significant figures

    The liposome technology creates a shield that keeps most of the drug out of direct contact with a patient’s blood, successfully dodging Amikacin’s severe side effects, which include deafness,

  • Hacking Innovation Hacking Innovation

    GrowAir is a transparent shield, consisting of tubes that purify air, which is then aimed into the nose and mouth of the child, and it is intended to replace the masks

  • Cybersecurity Cybersecurity

    A new political agreement to create a new legal structure called the EU-US Privacy Shield is being negotiated. ... Privacy Shield and safe harbour . The Directive requires that personal data can only be transferred outside the EEA to a territory

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare

    Also joining Wilmington is Sarah Shield (pictured left), who has worked in the pharmaceutical industry for 14 years. ... Prior to joining the team at Wilmington, Shield was national policy and partnership lead for AstraZeneca’s UK cardiovascular and

  • Shield Therapeutics’ CFO steps down Shield Therapeutics’ CFO steps down

    Richard Jones to leave the group in early 2017. Richard Jones is to step down from his position as chief financial officer at Shield Therapeutics early next year. ... Carl Sterritt, chief executive officer of Shield Therapeutics, said: “Richard has

  • Mereo BioPharma appoints CFO Mereo BioPharma appoints CFO

    2017. Jones joins the rare and specialty diseases clinical-stage company from Shield Therapeutics, where he most recently served as chief financial officer and company secretary. ... His extensive financial experience in healthcare industry, initially as

  • JPA adds to Washington team JPA adds to Washington team

    He previously worked for the agency Trahan, Burden, Charles where he managed marketing objectives for the likes of Blue Cross Blue Shield of Maryland and the Baltimore Ravens.

  • Horizon appoints board chair Horizon appoints board chair

    Shield. He held this role until from 2008 to 2011, when the company was acquired by Alere.

More from appointments
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

R&D protocol amendments
Rethinking trials: the pros and cons of protocol amendments
Protocol amendments occur often and can be beneficial, but the steps involved can be complex...
Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...

Infographics